We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Brookfield Asset Management
BAM
$87.1B
| $6.63M | 0.01% |
137,009
+446
| +0.3% | +$24.3K |
|
752
RPM International
RPM
$14.7B
| $6.63M | 0.01% |
57,355
-3,575
| -6% | -$435K |
|
753
Teck Resources
TECK
$32.4B
| $6.55M | 0.01% |
179,832
-130,155
| -42% | -$5.4M |
|
754
Disc Medicine
IRON
$3.09B
| $6.47M | 0.01% |
130,386
+904
| +0.7% | +$50.3K |
|
755
iShares Global Comm Services ETF
IXP
$561M
| $6.45M | 0.01% |
66,500
+21,500
| +48% | +$2.17M |
|
756
Solventum
SOLV
$14.5B
| $6.41M | 0.01% |
84,368
-2,660
| -3% | -$198K |
|
757
American Financial Group
AFG
$12B
| $6.4M | 0.01% |
48,776
+787
| +2% | +$102K |
|
|
TRML
758
DELISTED
Tourmaline Bio
TRML
| $6.39M | 0.01% |
419,883
| – | – |
|
759
Legend Biotech
LEGN
$3.99B
| $6.29M | 0.01% |
182,353
+92,684
| +103% | +$3.32M |
|
760
Ally Financial
ALLY
$13.5B
| $6.25M | 0.01% |
171,506
+3,090
| +2% | +$114K |
|
761
Futu Holdings
FUTU
$14.7B
| $6.22M | 0.01% |
60,738
-59,958
| -50% | -$6.14M |
|
762
Hormel Foods
HRL
$13.4B
| $6.14M | 0.01% |
198,504
+21,727
| +12% | +$645K |
|
763
Jacobs Solutions
J
$17B
| $6.01M | 0.01% |
50,183
+1,961
| +4% | +$252K |
|
764
Stanley Black & Decker
SWK
$15.5B
| $5.99M | 0.01% |
77,908
-11,859
| -13% | -$1,000K |
|
765
Annaly Capital Management
NLY
$17.4B
| $5.95M | 0.01% |
292,977
+11,003
| +4% | +$226K |
|
766
Vipshop
VIPS
$6.94B
| $5.93M | 0.01% |
378,451
+6,951
| +2% | +$105K |
|
767
Molson Coors Class B
TAP
$7.75B
| $5.91M | 0.01% |
97,128
+13,956
| +17% | +$804K |
|
768
Paycom
PAYC
$9.52B
| $5.83M | 0.01% |
26,696
| – | – |
|
769
Bio-Techne
TECH
$11.3B
| $5.8M | 0.01% |
98,920
+5,260
| +6% | +$356K |
|
770
Watts Water Technologies
WTS
$12.9B
| $5.79M | 0.01% |
28,379
-383
| -1% | -$80.3K |
|
771
Host Hotels & Resorts
HST
$15.6B
| $5.78M | 0.01% |
407,009
-101,585
| -20% | -$1.65M |
|
772
Nordson
NDSN
$17.3B
| $5.77M | 0.01% |
28,615
-6,832
| -19% | -$1.45M |
|
773
Manhattan Associates
MANH
$11.2B
| $5.74M | 0.01% |
33,194
-1,716
| -5% | -$357K |
|
774
Fox Class B
FOX
$23.5B
| $5.73M | 0.01% |
109,072
+9,963
| +10% | +$495K |
|
775
Erie Indemnity
ERIE
$13.5B
| $5.72M | 0.01% |
13,655
-1,110
| -8% | -$453K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.